Contrary to what is happening for people over fifty, rates of colon and rectal cancer are rising in younger adults.

While new colorectal cancers in older people have fallen consistently since 1985, rates for people under 50 have risen, particularly for rectal cancer.

Even more concerning, young people with colon cancer were diagnosed at later, less curable stages than those 50 or older. Almost two-thirds had a stage III or IV cancer compared to half of people diagnosed at a later age.

In the Archives of Internal Medicine, Nancy You, MD, of MD Anderson Cancer Center in Houston, and her colleagues ask, “Young-Onset Colorectal Cancer: Is It Time to Pay Attention?”

Read the rest of this entry »

Rectal cancer rates are increasing in people under 40, although rates of colon cancer have remained stable in younger people.

It isn’t clear why, but rectal cancer rates in this young group of men and women began increasing in 1984, rising about 3.8 percent a year.

Increases were similar for both sexes and all races. Read the rest of this entry »

Insurance makes a difference for people with rectal cancer.

Rectal cancer patients without insurance or covered by Medicaid are almost twice as likely to die within five years as those privately insured.

Not only are they diagnosed at a later stage, but fewer receive recommended treatments at every stage.

More than half of the difference between patients with private insurance and those without was due to differences in how early they were diagnosed and whether or not they got standard treatment. Read the rest of this entry »

Surgeons at M.D. Anderson Cancer Center in Houston have identified 87 genes that someday may tell doctors whether or not rectal cancer patients need surgery after chemotherapy and radiation.  The panel of genes predicted patients whose cancer appeared to be completely destroyed by the combination of chemotherapy and radiation before surgery, what is called pathological complete response.

Before it can become routine practice, the gene panel will need to be checked in another group of patients and clinical trials will need to be conducted to see if patients who have pathological complete responses and no surgery do as well as those who do have surgery. Read the rest of this entry »

In the hands of experts, laparoscopic surgery for rectal cancer was as successful as an open abdominal operation.  Cancer free survival after five years wasn’t any different, and cancer was no more likely to return in and around the rectum.

Even if surgeons had to change their approach during the operation and convert from laparoscopic to open surgery, outcomes were not affected. Read the rest of this entry »